GlassScriptPhysician profile
Christine Tran
NPI 1972576429
$1,786.44
in general payments reported to CMS, 2019-2025
25 companies · $305 in 2025
The $305 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $291 · 2020: $41.64 · 2021: $178 · 2022: $185 · 2023: $399 · 2024: $387 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,091.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,090.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $321.60 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $241.06 | 2022-2025 | |
| Abbvie INC. | $190.03 | 2021-2023 | Lo Loestrin Fe, Orilissa |
| Neotract INC. | $147.47 | 2019 | |
| Therapeuticsmd, INC. | $104.80 | 2020-2022 | |
| Millicent US INC | $99.58 | 2023-2025 | Femring, Intrarosa, Femlyv |
| Organon LLC | $91.76 | 2022-2025 | Nexplanon |
| Exact Sciences Corporation | $78.33 | 2024 | Cologuard Collection Kit |
| Renovia INC | $71.66 | 2019 | |
| Sumitomo Pharma America, INC. | $70.55 | 2023-2024 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $62.25 | 2021-2023 | |
| Pfizer INC. | $59.39 | 2023-2025 | |
| Sage Therapeutics, LLC | $34.61 | 2025 | Zurzuvae |
| Evofem Biosciences, INC. | $25.88 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $23.01 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $20.76 | 2019 | |
| Merck Sharp & Dohme LLC | $20.66 | 2023 | Gardasil 9 |
| Supernus Pharmaceuticals, INC. | $20.62 | 2025 | Qelbree |
| Avion Pharmaceuticals | $17.47 | 2022 | |
| Amag Pharmaceuticals, INC. | $17.28 | 2020 | |
| Hologic Sales and Service, LLC | $15.37 | 2019 | |
| Exeltis, USA INC. | $14.03 | 2024 | Slynd |
| Scynexis, INC. | $13.15 | 2022 | |
| Coopersurgical, INC. | $12.66 | 2022 | |
| Allergan, INC. | $12.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.